Figures and Tables

From the following article:

Recombinant biologics for treatment of bleeding disorders

Paul Bishop & Jeff Lawson

Nature Reviews Drug Discovery 3, 684-694 (August 2004)

doi:10.1038/nrd1443

Figure 1 - Recombinant biologics for treatment of bleeding disorders

Figure 1

Estimates of patients treated for major bleeding events and haemophilia prophylaxis in the industrialized world (2002).

Figure 2 - Recombinant biologics for treatment of bleeding disorders

Figure 2

The key enzymatic and cellular events leading to clot formation.

Figure 3 - Recombinant biologics for treatment of bleeding disorders

Figure 3

Enzymatic relationships within the coagulation pathway.

Table 1 - Recombinant biologics for treatment of bleeding disorders

Table 1

Incidence of coagulation factor deficiencies

Table 2 - Recombinant biologics for treatment of bleeding disorders

Table 2

Conventional modalities used in the treatment of bleeding

Table 3 - Recombinant biologics for treatment of bleeding disorders

Table 3

Recombinant biologics used for the treatment of bleeding disorders*